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is likely to bring high restenosis incidence and strong local
thrombogenic stimuli. Therefore, based on previous studies, a
pre-hoc possibility of important adverse events was predictable.
Aswidely accepted, off-label and potentially harmful techniques
should be used with great caution, selecting patients on an
individual basis and informing them of the experimental nature of
the technique. The study does not report whether a clinical
selection of patients was performed or whether an approval from
the local ethics committee and a specific informed consent were
obtained. It is our strong belief that conduction of a study on a new
therapeutic off-label technique with potentially severe concerns
should bear the same obligations as all other studies investigating
new drugs, devices, or a new indication for them. Therefore, a
research-oriented informed consent from the patients and an
ethical committee approval should be mandatory and clearly stated
in reports relating to these subjects.
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REPLY
We thank Dr. Pristipino and colleagues for their interesting
comments about our report. The opportunity to answer their
comments will allow clarification of some concerns regarding this
innovative approach.
Worse outcome compared to provisional T stenting (PTS). Our
report of the crush stenting experience is not meant to be directly
compared to the PTS as already reported by us (1). A number of
bifurcations with severe narrowing occur in both branches where
PTS is not conceivable as an intention-to-treat approach; the crush
technique is specifically designed for these types of lesions. It is
always misleading to try to compare different studies performed on
different types of bifurcations with a variety of different inclusion
criteria. We recognize that there is no substitute for appropriately
designed prospective randomized studies. This is the main reason
why we launched the Coronary bifurcations: Application of the
Crushing Technique Using Sirolimus-eluting stents (CACTUS)
trial, which prospectively evaluated the PTS technique versus the
crush technique (CT) in true bifurcational lesions.
Incidence of stent thrombosis of 4.4% with the CT. A 4.4%
incidence in 181 patients bears a 95% confidence interval of 2.3%
to 8.5%. In addition, it is important to point out that in
threepatients the thrombosis was intraprocedural and possibly
related to suboptimal anticoagulant or antiplatelet therapy,
whereas two other events occurred in a patient who prematurely
stopped antiplatelet therapy.
Very recently, we reported a 3.6% rate of cumulative stent
thrombosis after drug-eluting stent (DES) implantation in bifur-
cations in a prospective observational cohort study that included
2,229 patients treated with DESs (2). In this study, bifurcation
lesion treatment was identified as an independent predictor of
subacute (postprocedure to 30 days), late (30 days), and cumu-
lative thrombosis. However, no significant differences existed
regarding the incidence of thrombosis in bifurcations treated with
one versus two stents.
Kissing balloon inflation and success in recrossing. In our initial
experience with the CT we did not believe that recrossing into the
side branch so as to perform kissing balloon inflation was a
mandatory step. We performed kissing balloon inflation in about
one-third of cases when the angiographic result was not optimal.
The relatively high angiographic restenosis prompted us to always
recross into the side branch and perform final kissing inflation.
Our success in recrossing into the side branch in the experience
reported was 100% and continues to remain high. Availability of
improved wires and low-profile balloons makes recrossing into the
side branch and performance of balloon inflations a step that adds
only a few minutes to the procedure.
The modest results . . . and the three layers of struts. Ever since the
institution of routine high-pressure inflation into the side branch
and kissing balloon inflation, as reported in the study, we saw an
angiographic restenosis in the side branch of 11.1%, and in
many instances focal restenosis at the ostium of the side branch
is not clinically relevant. The problem of multiple layers of
struts appears more theoretical than practical owing to the fact
that the struts’ overlap is limited to 1 or 2 mm. Intravascular
ultrasound studies did not demonstrate any lumen compromise at
the level of the overlap in the main branch, and the real issue is
frequently an incomplete expansion of the lesion at the ostium of
the side branch (3).
Usage of off-label technique. We fully agree that any usage of a
device for an unlabeled indication must be very carefully performed
after having evaluated alternative solutions. The field of invasive
cardiology is full of situations in which devices are used outside the
labeling instructions; these responsible decisions allow treatment of
many patients who would otherwise receive a suboptimal therapy.
Careful off-label usage is essential to give initial information to
plan prospective studies designed to demonstrate safety and effi-
cacy. Coronary stenting in acute myocardial infarction is a typical
example of this path. The results we reported were obtained from
analyzing stenting in bifurcational lesions using the optimal
technique according to the operator. This experience was not a
predesigned study to compare different techniques. This type of
evaluation does not require a dedicated consent form in addition to
the one for the procedure being done. Using feedback from many
other operators, the CT, if applied to the appropriate bifurcations
and if properly performed, remains a valuable tool to treat
bifurcational lesions. Of course, we hope that dedicated stents
specifically designed for this lesion subset may further improve the
results in this important area of interventional cardiology.
1916 Correspondence JACC Vol. 47, No. 9, 2006
May 2, 2006:1904–17
*Antonio Colombo, MD, FACC
Flavio Airoldi, MD
Ioannis Iakovou, MD
Goran Stankovic, MD, FACC
Lei Ge, MD
*EMO Centro Cuore Columbus
Cardiac Catheterization Laboratory
Via Buonarroti 48
Milan, Lombardia 20145
Italy
E-mail: colombo@emocolumbus.it
doi:10.1016/j.jacc.2006.02.010
REFERENCES
1. Ge L, Airoldi F, Iakovou I, et al. Clinical and angiographic outcome
after implantation of drug-eluting stents in bifurcation lesions with the
crush stent technique: importance of final kissing balloon post-dilation.
J Am Coll Cardiol 2005;46:613–20.
2. Iakovou I, Schmidt T, Bonizzoni E, et al. Incidence, predictors, and
outcome of thrombosis after successful implantation of drug-eluting
stents. JAMA 2005;293:2126–30.
3. Costa RA, Mintz GS, Carlier SG, et al. Bifurcation coronary lesions
treated with the “crush” technique: an intravascular ultrasound analysis.
J Am Coll Cardiol 2005;46:599–605.
1917JACC Vol. 47, No. 9, 2006 Correspondence
May 2, 2006:1904–17
